| News

ChemAxon establishes subsidiary in Basel

06.11.2020

ChemAxon develops software for application in the chemicals and biopharma industries. Now, the Hungarian company has established a subsidiary in Basel. The customer base and economic conditions were cited as reasons for the choice of location.

The Hungarian company ChemAxon has established the ChemAxon GmbH subsidiary in Basel. The software company chose Basel on account of the connection to customers in the chemicals and biopharma industries as well as the economic conditions. In setting up the new location, it was supported by Basel Area Business & Innovation, the investment and innovation promotion agency.

“During the evaluation process and after the incorporation period I was really impressed with all the support and help ChemAxon and I received from BaselArea Business & Innovation,” explains Annamaria Kovacs, the Basel-based representative of ChemAxon.

With headquarters in Budapest, ChemAxon also has offices in the USA, Prague and Asia. Worldwide, ChemAxon has 150 employees. The company’s software products help to accelerate and enhance scientific discovery and collaboration. The solutions are tailored to the requirements of customers in the chemicals and biopharma sectors.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Bottmedical enters the market with innovative braces
Basel Area Business & Innovation, Innovation, Invest

Bottmedical enters the market with innovative braces

The Basel-based startup Bottmedical has developed clear braces made from bio-based polymers. After closing a successful financing round, the company...

Read More
TargImmune raises nearly 18 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

TargImmune raises nearly 18 million Swiss francs

The Basel-based biotechnology firm TargImmune has raised 17.7 million Swiss francs as part of a financing round. It now intends...

Read More
KetoSwiss launches first product in the USA
Basel Area Business & Innovation, Innovation, Invest

KetoSwiss launches first product in the USA

The Basel-based biotech startup KetoSwiss develops innovative therapies for neurological disorders. Following a successful capital increase, the company now has...

Read More
For Swiss startups, China might be closer than it seems
Basel Area Business & Innovation, Invest

For Swiss startups, China might be closer than it seems

China wants to strengthen domestic demand and be less dependent on imports. This policy has huge implications for the life...

Read More
Basel Area treads unique path
Basel Area Business & Innovation, Innovation, Invest

Basel Area treads unique path

Basel Area is responsible for both location and innovation promotion. This approach, which is unique across Switzerland, is very successful...

Read More
Alentis secures 67 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Alentis secures 67 million US dollars

The Basel-based biotechnology company Alentis Therapeutics has secured 67 million US dollars in a series B funding round. The funds...

Read More
1 2 3 46

Do you have a question? We'd like to hear from you.